Cite
Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?
MLA
Di Stadio, Arianna, et al. “Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?” Life (2075-1729), vol. 13, no. 1, Jan. 2023, p. 226. EBSCOhost, https://doi.org/10.3390/life13010226.
APA
Di Stadio, A., Bernitsas, E., La Mantia, I., Brenner, M. J., Ralli, M., Vaira, L. A., Colizza, A., Cavaliere, C., Laudani, M., Frohman, T. C., De Vincentiis, M., Frohman, E. M., & Altieri, M. (2023). Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)? Life (2075-1729), 13(1), 226. https://doi.org/10.3390/life13010226
Chicago
Di Stadio, Arianna, Evanthia Bernitsas, Ignazio La Mantia, Michael J. Brenner, Massimo Ralli, Luigi Angelo Vaira, Andrea Colizza, et al. 2023. “Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?” Life (2075-1729) 13 (1): 226. doi:10.3390/life13010226.